StockDrifts LogoStockDrifts

Palo Alto Investors 13F Portfolio

Portfolio Manager
Palo Alto Investors LP
Performance
+14.55% (2026 Q2)
AUM (13F)
$723.72M
# of Holdings
52
Performance Rank
Allocation (Top 20)
80.54%
Latest filing
Q2 2026

Palo Alto Investors LP Holdings Map

Top 50 Palo Alto Investors LP Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
PTCT
PTC THERAPEUTICS INC
10.36%918.8K$75.0M
-0.30%(-2.76K)
2025-Q2: 406.5K shares2025-Q3: 862.6K shares2025-Q4: 903.9K shares2026-Q1: 921.6K shares2026-Q2: 918.8K shares
$47.94(+50.96%)
2026-06-30
ACHC
ACADIA PHARMACEUTICALS INC
10.01%2.86M$72.5Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 2.86M shares
$26.18(+16.00%)
2026-06-30
INSM
INSMED INC
6.1%414.0K$44.1M
-0.31%(-1.29K)
2025-Q2: 865.1K shares2025-Q3: 491.8K shares2025-Q4: 489.5K shares2026-Q1: 415.3K shares2026-Q2: 414.0K shares
$18.99(+551.47%)
2026-06-30
ANAB
ANAPTYSBIO INC
5.63%603.5K$40.7M
-36.96%(-353.75K)
2025-Q2: 1.22M shares2025-Q3: 1.01M shares2025-Q4: 1.04M shares2026-Q1: 957.2K shares2026-Q2: 603.5K shares
$13.94(+319.33%)
2026-06-30
BMRN
BIOMARIN PHARMACEUTICAL INC
5.4%682.8K$39.1M
-0.35%(-2.40K)
2025-Q2: 840.5K shares2025-Q3: 754.0K shares2025-Q4: 746.3K shares2026-Q1: 685.2K shares2026-Q2: 682.8K shares
$78.54(-14.24%)
2026-06-30
DYN
DYNE THERAPEUTICS INC
5.06%1.65M$36.6M
-0.33%(-5.45K)
2025-Q2: 265.0K shares2025-Q3: 1.26M shares2025-Q4: 1.47M shares2026-Q1: 1.65M shares2026-Q2: 1.65M shares
$13.52(+90.09%)
2026-06-30
UTHR
UNITED THERAPEUTICS CORP
4.69%62.6K$33.9M
-0.35%(-222)
2025-Q2: 95.5K shares2025-Q3: 58.2K shares2025-Q4: 58.2K shares2026-Q1: 62.8K shares2026-Q2: 62.6K shares
$83.26(+507.45%)
2026-06-30
IRON
DISC MEDICINE INC
4.21%416.6K$30.5M
+3.72%(+14.93K)
2025-Q2: 145.7K shares2025-Q3: 224.3K shares2025-Q4: 317.5K shares2026-Q1: 401.7K shares2026-Q2: 416.6K shares
$62.80(+25.54%)
2026-06-30
BIIB
BIOGEN INC
4.19%140.3K$30.3M
-0.31%(-440)
2025-Q2: 205.8K shares2025-Q3: 185.7K shares2025-Q4: 183.6K shares2026-Q1: 140.7K shares2026-Q2: 140.3K shares
$256.88(-18.32%)
2026-06-30
IOVA
IOVANCE BIOTHERAPEUTICS INC
3.04%5.30M$22.0M
-16.59%(-1.05M)
2025-Q2: 3.43M shares2025-Q3: 7.62M shares2025-Q4: 7.12M shares2026-Q1: 6.35M shares2026-Q2: 5.30M shares
$4.09(+70.68%)
2026-06-30

About Palo Alto Investors LPโ€™s portfolio

Palo Alto Investors LP reports $723.72M in US-listed equity holdings across 52 positions in its most recent 13F filing. Its largest disclosed positions are PTCT (10.4%), ACHC (10.0%) and INSM (6.1%). The top 20 holdings account for 80.54% of reported assets. Its disclosed equity book has returned +31.44% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
PTCT โ€” 11.2% ($74.95M)ACHC โ€” 10.8% ($72.46M)INSM โ€” 6.6% ($44.14M)ANAB โ€” 6.1% ($40.74M)BMRN โ€” 5.8% ($39.07M)DYN โ€” 5.5% ($36.59M)UTHR โ€” 5.1% ($33.91M)IRON โ€” 4.5% ($30.47M)BIIB โ€” 4.5% ($30.31M)IOVA โ€” 3.3% ($22.03M)Other โ€” 36.7% ($246.07M)
63%in top 10
  • PTCT11.2%
  • ACHC10.8%
  • INSM6.6%
  • ANAB6.1%
  • BMRN5.8%
  • DYN5.5%
  • UTHR5.1%
  • IRON4.5%
  • BIIB4.5%
  • IOVA3.3%
  • Other36.7%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
3
ACHCACADIA PHARMACEUTICALS INC10.0%
SGMTSAGIMET BIOSCIENCES INC-A0.3%
NAMSNEWAMSTERDAM PHARMA CO NV0.2%
Added to
4
CMPXCOMPASS THERAPEUTICS INC+285.1%
CLDXCELLDEX THERAPEUTICS INC+34.9%
IRONDISC MEDICINE INC+3.7%
VSTMVERASTEM INC+25.8%
Trimmed
14
ANABANAPTYSBIO INC-37.0%
IOVAIOVANCE BIOTHERAPEUTICS INC-16.6%
TVTXTRAVERE THERAPEUTICS INC-27.3%
ORKAORUKA THERAPEUTICS INC - Restricted-44.1%
+10 more

Unlock alerts, watchlists & AI chat

Sign up free to track Palo Alto Investors LP, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Palo Alto Investors LPโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1306923). View Palo Alto Investors LPโ€™s 13F filings on SEC

More 13F analyses

View all